Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Exact Sciences Corporation - Common Stock (NQ:EXAS)

101.78 +0.22 (+0.22%)
Streaming Delayed Price Updated: 9:41 AM EST, Jan 2, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Exact Sciences Corporation - Common Stock

< Previous 1 2
...
15 16 17 18 19 20 21 22 Next >
News headline image
3 Crash-Ready Stocks to Buy in September ↗
History says this month can be scary. These stocks can get you through it. 
Via The Motley Fool
News headline image
This Cancer Screening Company Has A Better 5-Year Return Than Pfizer, Johnson & Johnson And Gilead ↗
Small-cap stocks have a history of outperforming large-cap names as they have the potential for rapid growth and have event-driven moves for share prices. A company focused... 
Via Benzinga
News headline image
3 Top Healthcare Stocks to Buy for August ↗
With excellent prospects, these three companies are built to last and today's prices are attractive. 
Via The Motley Fool
Unusual Options Activity Insight: Exact Sciences ↗
Exact Sciences (NASDAQ:EXAS) shares experienced unusual o... 
Via Benzinga
Unusual Options Activity Insight: Exact Sciences ↗
On Tuesday, shares of Exact Sciences (NASDAQ:EXAS) saw un... 
Via Benzinga
Expert Ratings for Exact Sciences ↗
Within the last quarter, Exact Sciences (NASDAQ:EXAS) has observed the fol... 
Via Benzinga
News headline image
The Daily Biotech Pulse: Pfizer, Bristol-Myers Squibb Earnings, Amgen Goes Shopping, GlaxoSmithKline-Vir's COVID-19 Antibody Treatment Supply Deal ↗
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 27) Bio-Rad Laboratories, Inc... 
Via Benzinga
News headline image
Why Exact Sciences Is Trading Higher Today ↗
Exact Sciences Corp (NASDAQ:EXAS) is trading higher Thursd... 
Via Benzinga
News headline image
44 Stocks Moving In Thursday's Mid-Day Session ↗
Gainers NanoVibronix, Inc. (NASDAQ: NAOV) shares jumped 47.6% to $2.8198 after the company announced it received registration approval for UroShield from TGA Australia.... 
Via Benzinga
News headline image
28 Stocks Moving in Thursday's Pre-Market Session ↗
Gainers LendingClub Corporation (NYSE: LC) shares rose 44.6% to $23.49 in pre-market trading after the company reported better-than-expected Q2 results and raised guidance. Acer... 
Via Benzinga
News headline image
The Daily Biotech Pulse: Merck's Disappointing Q2, Atreca Falls On Data, FDA Nod For Viatris, Nuvalent, Icosavax IPOs ↗
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 28) AbbVie Inc. (NYSE: ABBV)... 
Via Benzinga
News headline image
Exact Sciences (EXAS) Q2 2021 Earnings Call Transcript ↗
EXAS earnings call for the period ending June 30, 2021. 
Via The Motley Fool
Topics Earnings
News headline image
10 Stocks Moving In Wednesday's After-Hours Session ↗
Gainers Qualcomm (NASDAQ: QCOM) shares are trading higher after the company reported better-than-expected Q3 EPS and sales results and issued Q4 EPS guidance above estimates.... 
Via Benzinga
News headline image
Why PAVmed Soared by 12% on Wednesday ↗
The company tapped a respected figure in its industry as a board vice chairman. 
Via The Motley Fool
12 Health Care Stocks Moving In Wednesday's After-Market Session ↗
Gainers Corvus Pharmaceuticals (NASDAQ:CRVS 
Via Benzinga
News headline image
Exact Sciences: Q2 Earnings Insights ↗
Shares of Exact Sciences (NASDAQ:EXAS) moved lower in after-market trading after the company reported Q2 results. Quarterly Results Earnings per share were down 77.59% over the... 
Via Benzinga
News headline image
The Week Ahead In Biotech (July 25-31): Big Pharma Earnings, Iterum FDA Decision, Alzheimer's Conference, IPOs and More ↗
Biotech stocks rebounded in the week ended July 23, thanks to the broader market strength. The sector also benefitted from the optimism that was set in motion by the solid start... 
Via Benzinga
News headline image
Unusual Options Activity Insight: Exact Sciences ↗
Exact Sciences (NASDAQ:EXAS) shares experienced unusual options activity on Wednesday. The stock price moved down to $112.83 following the option alert. Sentiment: BULLISH... 
Via Benzinga
News headline image
10 Biggest Price Target Changes For Monday ↗
SVB Leerink raised Natera, Inc. (NASDAQ:NTRA) pr... 
Via Benzinga
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For June 15, 2021 ↗
Upgrades According to Raymond James, the prior rating for Welltower Inc (NYSE:WELL) was changed from Market Perform to Strong Buy. For the first quarter, Welltower had an... 
Via Benzinga
News headline image
Cramer Gives His Opinion On Novavax, Exact Sciences And More ↗
On CNBC's "Mad Money Lightning Round," Jim Cramer said he prefers Moderna Inc (NASDAQ: MRNA) over Novavax, Inc. (NASDAQ: NVAX). Philip Morris International Inc. (... 
Via Benzinga
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For June 3, 2021 ↗
Upgrades According to B of A Securities, the prior rating for Bloom Energy Corp (NYSE:BE) was changed from Underperform to Neutral. For the first quarter, Bloom Energy had... 
Via Benzinga
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For May 25, 2021 ↗
Upgrades For Appian Corp (NASDAQ:APPN), Macquarie upgraded the previous rating of Underperform to Neutral. For the first quarter, Appian had an EPS of $0.06, compared to... 
Via Benzinga
News headline image
Why Exact Sciences Stock Soared Today ↗
The company's Cologuard DNA test appears to be in good shape to maintain its market leadership. 
Via The Motley Fool
News headline image
Guardant Had Colon Cancer Data, But Rival Exact Popped — Here's Why ↗
Guardant and Exact are in a "win-win situation," an analyst said Thursday as EXAS stock surged on a comparison to Guardant in colon cancer detection. 
Via Investor's Business Daily
News headline image
Cathie Wood Buys $26M Disney Shares And Sells $13M In Netflix: What You Need To Know ↗
Cathie Wood-led Ark Investment Management on Friday bought 150,556 shares, worth about $26.15 million, in Walt Disney Co (NYSE: DIS), marking its debut in the media and... 
Via Benzinga
News headline image
Exact Sciences' First-Quarter Results Show Its Strength Under Pressure ↗
Despite ongoing pandemic-related headwinds, the medical diagnostic test maker's revenue grew. So how will it perform as those headwinds dissipate? 
Via The Motley Fool
News headline image
Cathie Wood Sheds $33.6M Alibaba Shares On Earnings Day ↗
Cathie Wood-led Ark Investment Management on Thursday shed 162,840 shares, worth about $33.6 million, in Alibaba Group Holding (NYSE: BABA) after the company posted its first... 
Via Benzinga
News headline image
Why Exact Sciences Doesn't Have Much to Worry About With Declining COVID Testing ↗
The company has other more significant growth drivers. 
Via The Motley Fool
News headline image
3 Cathie Wood Stocks for a $150 Billion Market That's Just Forming ↗
Falling costs are ushering in a new era of screening for a dreaded disease. 
Via The Motley Fool
< Previous 1 2
...
15 16 17 18 19 20 21 22 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.